These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36084923)

  • 1. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
    Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
    Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with
    Zhang L; Gui S; Xu Y; Zeng J; Wang J; Chen Q; Su L; Wang Z; Deng R; Chu F; Liu W; Jin X; Lu X
    Theranostics; 2021; 11(7):3417-3438. PubMed ID: 33537095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid-decorated alginate nanoparticles loaded hydrogel for the oral delivery of diferourylmethane in colorectal cancer.
    Abbasi M; Sohail M; Minhas MU; Mahmood A; Shah SA; Munir A; Kashif MU
    Int J Biol Macromol; 2023 Apr; 233():123585. PubMed ID: 36758757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
    Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
    Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
    Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
    Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
    He R; Yin C
    Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
    Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
    J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
    Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
    Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxylated Mesoporous Nanosilica Coated by Polyethylenimine Coupled with Gadolinium and Folic Acid: A Tumor-Targeted T(1) Magnetic Resonance Contrast Agent and Drug Delivery System.
    Zhang G; Gao J; Qian J; Zhang L; Zheng K; Zhong K; Cai D; Zhang X; Wu Z
    ACS Appl Mater Interfaces; 2015 Jul; 7(26):14192-200. PubMed ID: 26084052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of adenosine 5'-triphosphate using chitosan-coated mesoporous hydroxyapatite: A theranostic pH-sensitive nanoplatform with enhanced anti-cancer effect.
    Feiz MS; Meshkini A
    Int J Biol Macromol; 2019 May; 129():1090-1102. PubMed ID: 30170062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step precise targeting nanoplatform for tumor therapy via the alkyl radicals activated by the microenvironment of organelles.
    Wang L; Niu X; Song Q; Jia J; Hao Y; Zheng C; Ding K; Xiao H; Liu X; Zhang Z; Zhang Y
    J Control Release; 2020 Feb; 318():197-209. PubMed ID: 31672622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
    He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
    Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach.
    Rajpoot K; Jain SK
    Int J Biol Macromol; 2020 May; 151():830-844. PubMed ID: 32061847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel.
    Wan L; Wang X; Zhu W; Zhang C; Song A; Sun C; Jiang T; Wang S
    Int J Pharm; 2015 Apr; 484(1-2):207-17. PubMed ID: 25724138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
    Hu Y; He Y; Ji J; Zheng S; Cheng Y
    Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor.
    Movileanu C; Anghelache M; Turtoi M; Voicu G; Neacsu IA; Ficai D; Trusca R; Oprea O; Ficai A; Andronescu E; Calin M
    Int J Pharm; 2022 Sep; 625():122064. PubMed ID: 35952802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.